WEST PHARMACEUTICAL SERVICES, INC. Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) of $300.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised · last filed 2012-05-04
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $300.00K, a 75.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $300.00K, a 200.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $100.00K.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $1.90M.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2011 was $3.50M, a 66.67% increase from fiscal 2010.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2010 was $2.10M, a 47.50% decline from fiscal 2009.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2009 was $4.00M, a 32.20% decline from fiscal 2008.
- WEST PHARMACEUTICAL SERVICES, INC. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2008 was $5.90M.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $300.00K 10-Q · filed 2012-05-04 | $600.00K derived: sum of 2 quarters · filed 2012-05-04 | $700.00K derived: sum of 3 quarters · filed 2012-05-04 | $2.60M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $300.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $400.00K derived: sum of 2 quarters · filed 2012-03-01 | $2.30M derived: sum of 3 quarters · filed 2012-03-01 | $3.50M 10-K/A · filed 2012-03-01 |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $2.00M derived: sum of 2 quarters · filed 2011-11-07 | $3.20M 10-Q · filed 2011-11-07 | $3.30M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $1.90M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08 | $3.10M 10-Q/A · filed 2011-08-08 | $3.20M derived: sum of 3 quarters · filed 2012-05-04 | $3.20M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $1.20M 10-Q · filed 2012-05-04 | $1.30M derived: sum of 2 quarters · filed 2012-05-04 | $1.30M derived: sum of 3 quarters · filed 2012-05-04 | $1.30M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $100.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $100.00K derived: sum of 2 quarters · filed 2012-03-01 | $100.00K derived: sum of 3 quarters · filed 2012-03-01 | $2.10M 10-K/A · filed 2012-03-01 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $0.00 derived: sum of 2 quarters · filed 2011-11-07 | $2.00M 10-Q · filed 2011-11-07 | $3.90M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08 | $2.00M 10-Q/A · filed 2011-08-08 | $3.90M derived: sum of 3 quarters · filed 2012-03-01 | $4.90M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-03-31 | $2.00M 10-Q · filed 2011-05-05 | $3.90M derived: sum of 2 quarters · filed 2012-03-01 | $4.90M derived: sum of 3 quarters · filed 2012-03-01 | |
| 2009-12-31 | $1.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $2.90M derived: sum of 2 quarters · filed 2012-03-01 | $4.00M 10-K/A · filed 2012-03-01 | |
| 2009-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $2.10M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $1.10M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $5.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |